![Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings | Cancer Imaging | Full Text Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings | Cancer Imaging | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40644-020-00300-7/MediaObjects/40644_2020_300_Fig2_HTML.png)
Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings | Cancer Imaging | Full Text
![An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application | Journal of Nuclear Medicine An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/61/2/202/F3.large.jpg)
An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application | Journal of Nuclear Medicine
![68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy | Scientific Reports 68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-24688-3/MediaObjects/41598_2022_24688_Fig1_HTML.jpg)
68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy | Scientific Reports
![FDA Approves First Commercially Available PSMA PET Imaging Agent for Prostate Cancer | Imaging Technology News FDA Approves First Commercially Available PSMA PET Imaging Agent for Prostate Cancer | Imaging Technology News](http://www.itnonline.com/sites/default/files/PSMA_PET.jpg)
FDA Approves First Commercially Available PSMA PET Imaging Agent for Prostate Cancer | Imaging Technology News
![JCM | Free Full-Text | Diagnostic Performance of [18F]Fluorocholine and [68Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study JCM | Free Full-Text | Diagnostic Performance of [18F]Fluorocholine and [68Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study](https://www.mdpi.com/jcm/jcm-09-02308/article_deploy/html/images/jcm-09-02308-g001.png)
JCM | Free Full-Text | Diagnostic Performance of [18F]Fluorocholine and [68Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study
![Interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer | EJNMMI Research | Full Text Interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer | EJNMMI Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13550-020-0596-4/MediaObjects/13550_2020_596_Fig4_HTML.png)
Interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer | EJNMMI Research | Full Text
![Frontiers | Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective Frontiers | Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective](https://www.frontiersin.org/files/Articles/722277/fonc-11-722277-HTML/image_m/fonc-11-722277-g001.jpg)